Web Stats Provided By Google Analytics

Tuesday, October 1, 2013

Pivotal Phase 3 Data From Boehringer Ingelheim Corporation Hepatitis...

End-of-treatment results from STARTVerso 4 evaluating HIV/HCV co-infected patients will also be presented.

http://www.biospace.com/news_story.aspx?StoryID=310391&full=1
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)